{"altmetric_id":4151365,"counts":{"readers":{"citeulike":"0","mendeley":"22","connotea":"0"},"facebook":{"unique_users_count":4,"unique_users":["1592764200964519","546629912024172","178921298938171","1475061309405514"],"posts_count":4},"blogs":{"unique_users_count":1,"unique_users":[58032],"posts_count":1},"news":{"unique_users_count":1,"unique_users":["scicasts"],"posts_count":1},"total":{"posts_count":9},"twitter":{"unique_users_count":3,"unique_users":["silex_transl","vrichard_rouen","BadrillaLtd"],"posts_count":3},"downloads":{"publisher":{"views_granted_access":3708,"timeline":{"2015-06-12":144,"2015-06-13":376,"2015-06-14":119,"2015-06-15":259,"2015-06-16":169,"2015-06-17":110,"2015-06-18":54,"2015-06-19":25,"2015-06-20":8,"2015-06-21":5,"2015-06-22":51,"2015-06-23":36,"2015-06-24":28,"2015-06-25":44,"2015-06-26":60,"2015-06-27":37,"2015-06-29":24,"2015-06-30":33,"2015-07-01":19,"2015-07-02":17,"2015-07-03":11,"2015-07-04":20,"2015-07-05":11,"2015-07-06":27,"2015-07-07":32,"2015-07-08":45,"2015-07-09":24,"2015-07-10":8,"2015-07-11":3,"2015-07-12":17,"2015-07-13":11,"2015-07-14":12,"2015-07-15":15,"2015-07-16":11,"2015-07-17":9,"2015-07-18":6,"2015-07-19":3,"2015-07-20":15,"2015-07-21":11,"2015-07-22":7,"2015-07-23":7,"2015-07-24":3,"2015-07-25":1,"2015-07-26":14,"2015-07-27":16,"2015-07-28":12,"2015-07-29":6,"2015-07-30":6,"2015-07-31":13,"2015-08-01":6,"2015-08-02":14,"2015-08-03":8,"2015-08-04":4,"2015-08-05":11,"2015-08-06":4,"2015-08-08":2,"2015-08-09":2,"2015-08-10":7,"2015-08-11":7,"2015-08-12":6,"2015-08-13":8,"2015-08-14":5,"2015-08-15":4,"2015-08-16":7,"2015-08-17":7,"2015-08-18":9,"2015-08-19":10,"2015-08-20":4,"2015-08-21":2,"2015-08-22":1,"2015-08-23":11,"2015-08-24":6,"2015-08-25":7,"2015-08-26":9,"2015-08-27":1,"2015-08-28":4,"2015-08-29":3,"2015-08-30":6,"2015-08-31":8,"2015-09-01":3,"2015-09-02":5,"2015-09-03":5,"2015-09-04":6,"2015-09-05":3,"2015-09-06":3,"2015-09-07":3,"2015-09-08":5,"2015-09-09":5,"2015-09-10":3,"2015-09-11":3,"2015-09-13":2,"2015-09-14":10,"2015-09-15":8,"2015-09-16":24,"2015-09-17":4,"2015-09-18":2,"2015-09-19":7,"2015-09-20":2,"2015-09-21":6,"2015-09-22":2,"2015-09-23":34,"2015-09-24":12,"2015-09-25":6,"2015-09-27":2,"2015-09-28":11,"2015-09-29":1,"2015-09-30":2,"2015-10-01":10,"2015-10-02":15,"2015-10-03":2,"2015-10-05":7,"2015-10-06":3,"2015-10-07":18,"2015-10-09":8,"2015-10-10":4,"2015-10-11":2,"2015-10-12":6,"2015-10-13":10,"2015-10-14":11,"2015-10-15":14,"2015-10-16":9,"2015-10-17":2,"2015-10-18":2,"2015-10-19":5,"2015-10-20":4,"2015-10-21":4,"2015-10-22":6,"2015-10-23":6,"2015-10-24":1,"2015-10-25":1,"2015-10-26":5,"2015-10-27":9,"2015-10-28":5,"2015-10-29":5,"2015-10-30":8,"2015-10-31":1,"2015-11-01":2,"2015-11-02":8,"2015-11-03":4,"2015-11-04":21,"2015-11-05":14,"2015-11-06":3,"2015-11-07":1,"2015-11-08":2,"2015-11-09":5,"2015-11-10":4,"2015-11-11":12,"2015-11-12":4,"2015-11-13":11,"2015-11-15":7,"2015-11-16":10,"2015-11-17":7,"2015-11-18":4,"2015-11-19":2,"2015-11-20":8,"2015-11-21":1,"2015-11-22":3,"2015-11-23":2,"2015-11-24":2,"2015-11-25":1,"2015-11-26":3,"2015-11-27":3,"2015-11-28":2,"2015-11-29":6,"2015-11-30":8,"2015-12-01":6,"2015-12-02":13,"2015-12-03":2,"2015-12-04":3,"2015-12-05":7,"2015-12-06":9,"2015-12-07":15,"2015-12-08":6,"2015-12-09":1,"2015-12-10":5,"2015-12-11":4,"2015-12-12":1,"2015-12-13":1,"2015-12-14":10,"2015-12-15":2,"2015-12-16":5,"2015-12-17":5,"2015-12-18":6,"2015-12-19":1,"2015-12-20":1,"2015-12-21":7,"2015-12-22":2,"2015-12-23":4,"2015-12-24":5,"2015-12-25":2,"2015-12-26":3,"2015-12-27":2,"2015-12-28":2,"2015-12-29":3,"2015-12-30":1,"2015-12-31":2,"2016-01-02":1,"2016-01-03":2,"2016-01-04":9,"2016-01-05":4,"2016-01-06":3,"2016-01-07":2,"2016-01-08":5,"2016-01-10":3,"2016-01-11":3,"2016-01-12":5,"2016-01-13":7,"2016-01-14":2,"2016-01-15":2,"2016-01-16":3,"2016-01-17":4,"2016-01-18":5,"2016-01-19":32,"2016-01-20":4,"2016-01-21":5,"2016-01-22":5,"2016-01-23":3,"2016-01-24":3,"2016-01-26":5,"2016-01-27":2,"2016-01-28":6,"2016-01-29":3,"2016-01-30":5,"2016-01-31":2,"2016-02-01":5,"2016-02-02":7,"2016-02-03":6,"2016-02-04":4,"2016-02-05":6,"2016-02-06":1,"2016-02-08":1,"2016-02-09":1,"2016-02-10":3,"2016-02-11":5,"2016-02-12":1,"2016-02-14":6,"2016-02-15":7,"2016-02-16":1,"2016-02-17":3,"2016-02-18":3,"2016-02-19":10,"2016-02-20":3,"2016-02-21":8,"2016-02-22":4,"2016-02-23":6,"2016-02-24":1,"2016-02-25":9,"2016-02-26":4,"2016-02-27":2,"2016-02-29":5,"2016-03-02":2,"2016-03-03":3,"2016-03-04":4,"2016-03-05":3,"2016-03-06":4,"2016-03-07":3,"2016-03-08":9,"2016-03-09":1,"2016-03-10":5,"2016-03-11":2,"2016-03-13":3,"2016-03-14":1,"2016-03-15":4,"2016-03-16":5,"2016-03-17":10,"2016-03-19":1,"2016-03-20":1,"2016-03-21":5,"2016-03-22":9,"2016-03-23":2,"2016-03-24":3,"2016-03-25":7,"2016-03-26":1,"2016-03-27":1,"2016-03-29":3,"2016-03-30":2,"2016-03-31":5,"2016-04-01":4,"2016-04-02":1,"2016-04-03":2,"2016-04-04":10,"2016-04-05":1,"2016-04-06":8,"2016-04-07":4,"2016-04-08":7,"2016-04-10":4,"2016-04-11":10,"2016-04-12":18,"2016-04-13":2,"2016-04-14":3,"2016-04-15":10,"2016-04-16":9,"2016-04-17":31,"2016-04-18":7,"2016-04-19":12,"2016-04-21":5,"2016-04-22":9,"2016-04-23":3,"2016-04-24":1,"2016-04-25":3,"2016-04-26":9,"2016-04-27":7,"2016-04-28":4,"2016-04-29":4,"2016-04-30":2,"2016-05-01":1,"2016-05-02":1,"2016-05-03":1,"2016-05-04":3,"2016-05-05":5,"2016-05-06":3,"2016-05-07":3,"2016-05-08":6,"2016-05-09":4,"2016-05-10":7,"2016-05-11":12,"2016-05-12":9,"2016-05-13":2,"2016-05-14":3,"2016-05-15":2,"2016-05-16":8,"2016-05-17":5,"2016-05-18":3,"2016-05-19":4,"2016-05-20":1,"2016-05-21":2,"2016-05-23":7,"2016-05-24":3,"2016-05-25":1,"2016-05-26":4,"2016-05-27":1,"2016-05-28":1,"2016-05-29":1,"2016-05-30":2,"2016-05-31":8,"2016-06-01":7,"2016-06-02":9,"2016-06-03":4,"2016-06-04":2,"2016-06-05":3,"2016-06-06":6,"2016-06-07":6,"2016-06-08":6,"2016-06-09":5,"2016-06-11":1,"2016-06-13":11,"2016-06-14":3,"2016-06-15":6,"2016-06-16":3,"2016-06-17":10,"2016-06-19":2,"2016-06-20":8,"2016-06-21":11,"2016-06-22":9,"2016-06-23":7,"2016-06-24":2,"2016-06-27":1,"2016-06-28":9,"2016-06-29":5,"2016-06-30":5,"2016-07-01":1,"2016-07-02":1,"2016-07-04":7,"2016-07-05":4,"2016-07-06":2,"2016-07-10":5,"2016-07-12":11,"2016-07-13":2,"2016-07-14":5,"2016-07-15":2,"2016-07-18":2,"2016-07-19":3,"2016-07-20":3,"2016-07-21":4,"2016-07-23":2,"2016-07-25":5,"2016-07-26":6,"2016-07-27":4,"2016-07-28":2,"2016-07-29":1,"2016-07-30":1,"2016-07-31":1,"2016-08-01":4,"2016-08-02":2,"2016-08-05":3}}}},"selected_quotes":["après l'échec de la thérapie génique SERCA, voici le retour de la pharmacologie classique petite molécule. Youpi!"],"citation":{"abstract":"Decreased activity and expression of the cardiac sarcoplasmic reticulum calcium ATPase (SERCA2a), a critical pump regulating calcium cycling in cardiomyocyte, are hallmarks of heart failure. We have previously described a role for the small ubiquitin-like modifier type 1 (SUMO-1) as a regulator of SERCA2a and have shown that gene transfer of SUMO-1 in rodents and large animal models of heart failure restores cardiac function. Here, we identify and characterize a small molecule, N106, which increases SUMOylation of SERCA2a. This compound directly activates the SUMO-activating enzyme, E1 ligase, and triggers intrinsic SUMOylation of SERCA2a. We identify a pocket on SUMO E1 likely to be responsible for N106's effect. N106 treatment increases contractile properties of cultured rat cardiomyocytes and significantly improves ventricular function in mice with heart failure. This first-in-class small-molecule activator targeting SERCA2a SUMOylation may serve as a potential therapeutic strategy for treatment of heart failure.","altmetric_jid":"4f6fa62f3cf058f610008259","authors":["Changwon Kho","Changwon Kho","Ahyoung Lee","Dongtak Jeong","Jae Gyun Oh","Przemek A. Gorski","Kenneth Fish","Roberto Sanchez","Robert J. DeVita","Geir Christensen","Russell Dahl","Roger J. Hajjar"],"doi":"10.1038/ncomms8229","first_seen_on":"2015-06-14T06:28:12+00:00","funders":["niehs","nhlbi","phs"],"issns":["2041-1723"],"journal":"Nature Communications","links":["http://www.nature.com/ncomms/2015/150612/ncomms8229/full/ncomms8229.html","http://dx.doi.org/10.1038/ncomms8229"],"pmid":"26068603","pubdate":"2015-06-12T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Multidisciplinary","scheme":"era"}],"subjects":["biology","science"],"title":"Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure","type":"article","volume":"6","mendeley_url":"http://www.mendeley.com/research/smallmolecule-activation-serca2a-sumoylation-treatment-heart-failure"},"altmetric_score":{"score":17.854,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":17.854},"context_for_score":{"all":{"total_number_of_other_articles":5328421,"mean":6.2425338453062,"rank":290486,"this_scored_higher_than_pct":94,"this_scored_higher_than":5038150,"rank_type":"exact","sample_size":5328421,"percentile":94},"similar_age_3m":{"total_number_of_other_articles":179855,"mean":8.6436055356013,"rank":15068,"this_scored_higher_than_pct":91,"this_scored_higher_than":164786,"rank_type":"exact","sample_size":179855,"percentile":91},"this_journal":{"total_number_of_other_articles":8838,"mean":35.254227000113,"rank":3268,"this_scored_higher_than_pct":63,"this_scored_higher_than":5571,"rank_type":"exact","sample_size":8838,"percentile":63},"similar_age_this_journal_3m":{"total_number_of_other_articles":702,"mean":32.720291012839,"rank":261,"this_scored_higher_than_pct":62,"this_scored_higher_than":441,"rank_type":"exact","sample_size":702,"percentile":62}}},"demographics":{"poster_types":{"member_of_the_public":3},"users":{"twitter":{"cohorts":{"Members of the public":3}},"mendeley":{"by_status":{"Lecturer > Senior Lecturer":1,"Student  > Bachelor":2,"Researcher":7,"Other":1,"Professor":1,"Student  > Ph. D. Student":9,"Student  > Doctoral Student":1},"by_discipline":{"Medicine and Dentistry":2,"Chemistry":1,"Agricultural and Biological Sciences":14,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":4}}},"geo":{"twitter":{"FR":1,"GB":1},"mendeley":{"FR":2}}},"posts":{"twitter":[{"url":"https://twitter.com/silex_transl/status/609970436168757248","posted_on":"2015-06-14T06:27:39+00:00","license":"datasift","citation_ids":[4151365],"author":{"name":"silex知の文献サービス","url":"http://silex-transl.com/","image":"https://pbs.twimg.com/profile_images/623877188203319296/HvACqB8r_normal.jpg","description":"バイオニュース、ライフサイエンスなどの話題を主にツイートしています。\n医学翻訳を中心とした文献サービスhttp://silex-transl.com","id_on_source":"silex_transl","tweeter_id":"3220106425","geo":{"lt":null,"ln":null},"followers":36},"tweet_id":"609970436168757248"},{"url":"https://twitter.com/vrichard_rouen/status/610389305735938048","posted_on":"2015-06-15T10:12:05+00:00","license":"datasift","citation_ids":[4151365],"author":{"name":"Vincent Richard","url":"http://www.insermu1096.fr","image":"https://pbs.twimg.com/profile_images/522759616359174144/ftNWzdui_normal.jpeg","description":"Professeurs de Universités - Praticien Hospitalier Pharmacologie, Directeur d'Unité Inserm Recherche Cardiovasculaire, CHU et Faculté de Médecine Rouen","id_on_source":"vrichard_rouen","tweeter_id":"545481451","geo":{"lt":49.44313,"ln":1.09932,"country":"FR"},"followers":120},"tweet_id":"610389305735938048"},{"url":"https://twitter.com/BadrillaLtd/status/616146513270587392","posted_on":"2015-07-01T07:29:10+00:00","license":"datasift","citation_ids":[4151365],"author":{"name":"Badrilla","url":"http://badrilla.com","image":"https://pbs.twimg.com/profile_images/565530071780167680/BeZO3Xn9_normal.png","description":"Badrilla is an established life science company providing high quality reagents to the #cardiovascular research community.","id_on_source":"BadrillaLtd","tweeter_id":"403440836","geo":{"lt":53.79648,"ln":-1.54785,"country":"GB"},"followers":141},"tweet_id":"616146513270587392"}],"news":[{"title":"New Powerful Drug Candidate Can Improve a Failing Heart’s Function, Study Finds","url":"http://scicasts.com/bio-it/1858-drug-development/9531-new-powerful-drug-candidate-can-improve-a-failing-heart-s-function-study-finds/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed:%20scicasts/news%20(Scicasts%20–%20Democratizing%20Science™|%20Latest%20Developments)","posted_on":"2015-06-15T12:53:21+00:00","license":"public","citation_ids":[4151365],"summary":"New York, NY (Scicasts) — An experimental drug improves the ability of heart muscle cells damaged by heart failure to pump blood, according to the results of a study led by Icahn School of Medicine at Mount Sinai researchers.","author":{"name":"Scicasts","url":"http://scicasts.com/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/310/normal/Screen_Shot_2016-02-02_at_17.16.41.png?1454433412"}}],"facebook":[{"title":"Timeline Photos","url":"https://www.facebook.com/permalink.php?story_fbid=475523709277927&id=178921298938171","posted_on":"2015-06-14T13:21:01+00:00","license":"public","citation_ids":[4151365],"summary":"A small molecule to prevent heart attack by activating calcium channel\n\nDecreased activity and expression of the cardiac sarcoplasmic reticulum calcium ATPase (SERCA2a), a critical pump regulating calcium cycling in cardiomyocyte, are hallmarks of heart fa","author":{"name":"Science Mission","url":"https://www.facebook.com/178921298938171","facebook_wall_name":"Science Mission","image":"https://graph.facebook.com/178921298938171/picture","id_on_source":"178921298938171"}},{"title":"Timeline Photos","url":"https://www.facebook.com/permalink.php?story_fbid=1633388500239460&id=1475061309405514","posted_on":"2015-06-14T18:35:34+00:00","license":"public","citation_ids":[4151365],"summary":"New powerful drug candidate can improve a failing heart’s function:\n\n* An experimental drug improves the ability of heart muscle cells damaged by heart failure to pump blood.\n\n* Like most currently available drugs, the study compound, N106, is a \"small mol","author":{"name":"Pharmacology - Medicine","url":"https://www.facebook.com/1475061309405514","facebook_wall_name":"Pharmacology - Medicine","image":"https://graph.facebook.com/1475061309405514/picture","id_on_source":"1475061309405514"}},{"url":"https://www.facebook.com/permalink.php?story_fbid=1611769479063991&id=1592764200964519","posted_on":"2015-06-14T06:45:53+00:00","license":"public","citation_ids":[4151365],"summary":"心臓Ca++ATPaseのSUMO化を活性化して心不全を治療する分子発見。ラット実験成功。\nhttp://t.co/q0fY7Rj2CR","author":{"name":"Silex - サイレックス　知の文献サービス","url":"https://www.facebook.com/1592764200964519","facebook_wall_name":"Silex - サイレックス　知の文献サービス","image":"https://graph.facebook.com/1592764200964519/picture","id_on_source":"1592764200964519"}},{"title":"Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure : Nature...","url":"https://www.facebook.com/permalink.php?story_fbid=977055012314991&id=546629912024172","posted_on":"2015-07-08T01:22:21+00:00","license":"public","citation_ids":[4151365],"summary":"Journal club 2015/07/07\n研究室の抄読会です。\n\n筋小胞体Ca ATPase (SERCA2a)は心筋細胞内Ca動態を制御するタンパクで、心不全時に機能が低下します。著者らは、SUMO-1（small ubiquitin-like modifier type 1）によるSUMO化がSERCA2aの機能調節に重要で、SUMO-1の遺伝子導入により実験動物の心機能が改善することを報告しています。本論文では、SERCA2aのSUMO化を促進する小分子N106を同定し、その機能を解析しました。","author":{"name":"群馬大学臓器病態内科学（第二内科：循環器・呼吸器内科）","url":"https://www.facebook.com/546629912024172","facebook_wall_name":"群馬大学臓器病態内科学（第二内科：循環器・呼吸器内科）","image":"https://graph.facebook.com/546629912024172/picture","id_on_source":"546629912024172"}}],"blogs":[{"title":"CardioBreak: Off-Label Talk, More $$ for PAD Balloons, VAD Recall","url":"http://www.medpagetoday.com/Cardiology/Atherosclerosis/52143","posted_on":"2015-06-15T17:23:00+00:00","license":"public","citation_ids":[4151365,3896836,4131000],"summary":"(MedPage Today) -- Recent developments of interest in cardiovascular medicine","author":{"name":"MedPage Today Cardiovascular","url":"http://www.medpagetoday.com/rss/Cardiology.xml","description":"Physicians...get the latest breaking news on Cardiology. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals."}}]},"score":17.854,"images":{"small":"https://altmetric-badges.a.ssl.fastly.net/?size=64&score=18&types=mbtttfff","medium":"https://altmetric-badges.a.ssl.fastly.net/?size=100&score=18&types=mbtttfff","large":"https://altmetric-badges.a.ssl.fastly.net/?size=180&score=18&types=mbtttfff"}}